Life under FDAAA: Four months of post-approval studies and REMS
01 August 2008
Sue Sutter
Please Login to read the full article.
01 August 2008
Sue Sutter
sue.sutter@informa.com
The
FDAhas not hesitated to use its new safety powers since they took effect on March 25th. A review of original and supplemental NDA and BLA approval letters on the FDA's website indicates that, through to July 24th, the agency has required mandatory postmarketing studies for no less than 18 products,...
Please Login to read the full article.
RELATED CONTENT
NEWS
- US Capitol Capsule: Obama wants one-stop shop for patents, trade & small biz aid
- US Capitol Capsule: Deal making starts on FY 2012 FDA budget, with federal shutdown again looming
- FDA staff argue Avastin benefit in breast cancer not worth the risk
- US Capitol Capsule: Health reform extends Medicare solvency, but programme to go bust by 2024
FEATURES
Other Informa Features
EVENTS
28 February 2012
Pestana Chelsea Bridge Hotel London
04 March 2012
The Marriott World Center, Orlando, Florida
26 March 2012
Copenhagen, Denmark
JOB OF THE WEEK
Promote your vacancy here
